MedPath
HSA Approval

CALCIUM GLUCONATE INJECTION USP 10%

SIN08451P

CALCIUM GLUCONATE INJECTION USP 10%

CALCIUM GLUCONATE INJECTION USP 10%

November 24, 1995

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Regulatory Information

FRESENIUS KABI (SINGAPORE) PTE LTD

FRESENIUS KABI (SINGAPORE) PTE LTD

Therapeutic

General Sale List

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

A12AA20

calcium (different salts in combination)

Manufacturer Information

FRESENIUS KABI (SINGAPORE) PTE LTD

AMERICAN PHARMACEUTICAL PARTNERS INC

Active Ingredients

CALCIUM GLUCONATE

94 mg/ml

Calcium gluconate

CALCIUM SACCHARATE TETRAHYDRATE

4.5 mg/ml

Gatifloxacin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

CALCIUM GLUCONATE INJECTION USP 10% - HSA Approval | MedPath